Aims/hypothesis There is evidence from mouse models and humans that alterations in insulin action in the brain are accompanied by an obese phenotype; however, the impact of insulin with regard to behavioural aspects such as locomotion is unknown. Methods To address insulin action in the brain with regard to cortical activity in distinct frequency bands and the behavioural consequences, the insulin signalling pathway was followed from the receptor to electrical activity and locomotion. Western blot analysis, electrocorticograms with intracerebroventricular (i.c.v.) application of insulin, and measurements of locomotor activity were performed in lean and obese, as well as Toll-like receptor (TLR) 2/4-deficient, mice.
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Introduction
Insulin is required for a variety of regulatory functions in multiple tissues such as induction of glucose uptake in skeletal muscle, suppression of hepatic glucose production and inhibition of lipolysis in adipose tissue. In addition to the classic insulin-sensitive tissues, the brain has emerged as a major target of insulin action in rodents as well as in humans [1] [2] [3] [4] [5] . There is increasing evidence that adequate insulin receptor signalling is required for neuronal survival [6] , regulation of food intake [7] , determination of lifespan [8] and adequate suppression of hepatic glucose production [9] ; however, the insulin-specific activation patterns in cortical activity, their functional consequences and molecular mechanisms are much less clear.
Insulin receptors are expressed all over the brain. The highest densities are in the hypothalamus, hippocampus, olfactory bulb and cerebrocortical tissues, where they display distinct functions [10] and promote tyrosine phosphorylation of proteins that engage in various downstream signalling pathways, including the insulin receptor substrate proteins, and the phosphatidylinositol-3 (PI3) kinase/AKT pathway [11] .
We recently demonstrated, using magnetoencephalography (MEG) measurements, that in humans insulin modifies cortical activity in distinct frequency bands, dependent on age, obesity, genetic variations and levels of NEFA. In particular, insulin was able to enhance cortical activity in the beta frequency spectrum in lean and young humans [12] , while obese and older individuals displayed insulin resistance [1] . In parallel, an increase in insulin levels led to an improvement in the theta frequency band in normalweight individuals, while obesity, elevated levels of NEFA and genetic variants associated with obesity failed to increase cortical activity in the theta frequency band [1, 13] . As all of these data were obtained with hyperinsulinaemic-euglycaemic clamp conditions, with permanent insulin application in the periphery combined with a single MEG measurement after 60 min of insulin infusion, it was not possible to monitor the kinetics closely nor the behavioural aspects in this setting.
To determine the kinetics of insulin action in the brain with regard to brain activity in distinct frequency bands, and to better understand the functional consequences and molecular pathways that are relevant in the pathophysiological state, we established electrocorticogram (ECoG) measurements [14, 15] in mice in combination with a cannula placed in the lateral ventricle to deliver substances directly. Thereby, insulin action could be tightly linked to activation patterns in electrical activity in the mouse brain and finally to behaviour.
By using this approach, the consequences of modulating insulin signalling in brain tissues by obesity and effects of pharmacological inhibition of ion channels were detected and correlated to brain activity and locomotion.
Methods
Animals We obtained C57BL/6NCrl male mice from Charles River Laboratories (Sulzfeld, Germany). They were maintained on a 12 h light-dark cycle and kept on either chow or were weaned on a high-fat diet for 8 weeks [16] . Mice with a knockout for Tlr2 on a C3H/HeJ background (C3H/HeJ/TLR2-KO) were obtained from H. Schild (Institute for Immunology, Johannes Gutenberg University, Mainz, Germany) who originally received them from H. Wagner (Institute of Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany) [17] . All procedures were conducted according to the guidelines of laboratory animal care and were approved by the local governmental commission for animal research.
In vivo stimulation and western blot analysis For in vivo stimulation, a bolus of human insulin (Novo Nordisk, Bagsvard, Denmark; 1 U/mouse for 5 min) was injected into the inferior vena cava of overnight-fasted mice. Control mice received a comparable amount of NaCl. Total brain tissues were removed and homogenised at 4°C. Homogenates were allowed to solubilise for 15 min on ice and clarified by centrifugation at 12×000 g for 20 min. To detect tyrosine phosphorylation of the insulin receptor or insulin receptor substrate 2 (IRS2) proteins, lysates containing equal amounts of protein were immunoprecipitated with antibodies directed against insulin receptor (IR) [18] or IRS2 (Millipore, Schwalbach, Germany). Visualisation of immunocomplexes after gel electrophoresis and western blotting was performed using PY 20 antibodies (Santa Cruz, La Jolla, CA, USA) and the non-radioactive enhanced chemiluminescence system ECL. Equal protein amounts were verified using β-tubulin antibodies (Millipore).
Chronic i.c.v. cannulation and implantation of electrocorticography telemetry transmitters At least 1 week before experimentation, each mouse had an implantable telemetry electrocorticography transmitter inserted and was instrumented with a guide cannula for microinjection of substances into the lateral ventricles. Briefly, animals were anaesthetised with isoflurane (5% [vol./vol.] induc-tion, 1.5% [vol./vol.] maintenance) and placed in a stereotaxic head holder. The body of the telemetry transmitter was implanted subcutaneously and two lead wires were connected to screws placed epidurally 1 mm anterior to lambda and 1 mm left to the sutura sagittalis for the recording electrode, and 1 mm anterior to bregma and 1 mm right to the sutura coronaria for the reference electrode. A sterile 27 G stainless steel cannula 6 mm in length was implanted in the left lateral ventricle of the brain with the following coordinates: 0.3 mm posterior and 1 mm lateral relative to bregma, and 3.0 mm down the skull surface. Electrodes, screws and cannula were then fixed in place with dental acrylic cement, and the scalp sutured closely around the resulting wound with non-absorbable 5-0 suture material (Ethilon polyamide; Ethicon, Norderstedt, Germany). A tubing dummy prevented blockage of the cannula. The correct position of the i.c.v. cannula was verified at the end of the experiments by dye injection into the ventricles before animals were killed.
Intracerebroventricular injection and locomotor activity Mice deprived of food overnight but with free access to water were injected by connecting the cannula via a polyethylene catheter to a microinjector (CMA/Microdialysis, Solna, Sweden). Compounds injected i.c.v. were dissolved in sterile NaCl solution and delivered in a volume of 2 µl over 1 min.
The mice received an injection of either human insulin (3.75 mU total, Novo Nordisk), vehicle (0.9% [wt/vol.] NaCl), wortmannin (0.01 µg total 30 min prior to insulin; Sigma Aldrich, Taufkirchen, Germany) or margatoxin (5 ng total, Sigma Aldrich) in random order 4 days apart. Telemetry signals (ECoG and locomotor activity) were recorded continuously for 120 min post injection processed by a Data-Sciences analogue converter (Data Exchange Matrix, DSI, St Paul, MN, USA) and stored digitally using the Dataquest A.R.T. 3.1 software (DSI). Electrocortical activity was sampled at 250 Hz with a filter cut-off of 40 Hz. Locomotor activity was measured by detecting the changes in signal strength that occurred as the animals moved about their cages. Changes in signal strength of more than a predetermined threshold generated a digital pulse, which was counted by the data-acquisition system. For detection of locomotor activity, the transmitter itself had to move.
Intraperitoneal glucose tolerance test Intraperitoneal glucose tolerance tests were performed in mice after a 16 h overnight fast. Mice were injected i.p. with 2 g D-glucose/kg body weight, and blood glucose concentrations were determined in tail bleeds using a Glucometer Elite (Bayer, Elkhart, IN, USA) at 0, 15, 30, 60 and 120 min.
Assay of PI3 kinase activity Lean and obese mice were injected i.v. with either NaCl, insulin (1U/mouse for 5 min) or wortmannin (15 µg/kg mouse for 30 min) followed by insulin, and brain lysates were immunopurified with anti-PY20 antibodies (Santa Cruz) and immunocomplexes were adsorbed to protein A-Sepharose for 12 h. Immunoprecipitates were washed three times and pellets were directly incubated with 0.1 mg/ml L-α-phosphatidylinositol (Sigma) and 50 μmol/l [γ 32 P]-ATP (Perkin Elmer, Waltham, MA, USA) at room temperature for 10 min. After addition of 150 μl of 1 mol/l HCl, lipids were extracted twice with 450 μl chloroform/methanol (1:1 by volume). Products were separated by thin layer chromatography as described [19] . 32 Plabelled phospholipids were detected by autoradiography.
Data analysis and statistics
The data analysis for ECoG measurements was performed as previously described [15] . Briefly, fast Fourier transformation (FFT) for delta (0.5-4 Hz), theta (4-8 Hz), alpha (8-12 Hz) and beta (12-30 Hz) frequency bands was used to calculate the power spectral density. Basal results for untreated lean and obese C57BL/ 6NCrl mice as well as TLR2/4-deficient mice and the corresponding C3H/HeJ control group were recorded as absolute ECoG power in (µV 2 /Hz). From our experience, inter-individual variation in baseline cortical activity becomes noticeable after i.c.v. application within the subsequent 120 min recording period because of stress inducement. To exclude such inter-individual variation in baseline cortical ECoG activity of lean and obese C57BL/ 6NCrl mice, the data for the ECoG power density are expressed as percentage change from baseline (vehicle) with 0% as baseline. Data are presented as mean±SEM.
The total number of animals tested in each group is indicated by n, and the experiments were separately performed. A p value <0.05 was considered to indicate statistical significance. Differences between multiple groups were carried out using one-way analysis of variance. When appropriate, we used the non-parametric Wilcoxon/ Kruskal-Wallis rank test. The groups were compared with a post hoc Tukey Kramer HSD comparison test. All analyses were performed using the software package JMP 4.0 (SAS Institute, Cary, NC, USA).
Results
Insulin-mediated alterations in cortical activity estimated by electrocorticography and correlation to locomotor activity To determine insulin-mediated activation patterns in cortical activity, insulin was administered by intracerebroventricular injection and modulation of brain activity in certain frequency bands was followed from electrocorticogram recordings (Fig. 1 a-h ). There was an increase in cortical beta and alpha activity (Fig. 1 a- (Fig. 1e , g, black bars) and delta (Fig. 1f , h, black bars) as previously suggested by our MEG measurements in normal-weight humans. Of note, insulin applied i.c.v. promoted cortical activity in the slow frequency bands with a first peak between minutes 0 and 40 and a second 80-120 min post injection ( Fig. 1 e-h, black bars). As insulin signalling in the brain involves activation of PI3-kinase, we determined insulin-mediated brain activity in the presence of wortmannin in lean mice (Fig. 1a, insert) . Clearly, induction in all of the frequency bands was abolished using wortmannin prior to insulin administered i.c.v., suggesting that the insulinmediated increase in these frequency bands is PI3-kinase dependent ( Fig. 1 a-h , dashed bars).
While it was not possible to correlate activity in the slow frequency band with behavioural readouts in human studies using the hyperinsulinaemic-euglycaemic clamp technique and MEG, it was clearly shown in rodents that active exercise resulted in power increases in the theta frequency band [20] . To translate insulin-mediated modulation in the slow frequency band to behaviour, locomotion in freely moving mice following i.c.v. administration of insulin was monitored by a permanently implanted telemetric sensor. To validate the association of brain activity in the slow frequency bands with locomotor activity, locomotion was analysed in the 0-40, 40-80 and 80-120 min intervals in the post-injection period. Clearly, insulin-mediated changes in the theta and delta frequency bands following insulin injection were accompanied by an increase in locomotor activity, with its most prominent effect within the first 40 min following insulin injection and between minutes 80 and 120 (Fig. 1i, black bars) when cortical activity in the theta and delta band was enhanced. Consistent with these results, insulin failed to stimulate locomotion after pretreatment with wortmannin (Fig. 1i, dashed period (*p<0.05; n=3 per group). c Locomotor activity of lean (black circles, n=8) and obese (white circles, n=8) C57BL/6Crl mice during the day (07:00-19:00 hours) and night (19:00-07:00 hours) cycles.
Results from an average of a 4 day period are given. d Quantification of locomotor activity of lean (black) and obese (grey) C57BL/6Crl mice over an average of a 12 h day and 12 h night cycle period ± SEM (*p< 0.05; n=8 per group). e Locomotor activity following i.c.v. application of NaCl or insulin (3.75 mU total) in overnight-fasted lean (black) and obese (grey) C57BL/6Crl mice. Quantification of locomotor activity in counts/min ± SEM for the 120 min measurement, n=4 (*p<0.05). f Quantification of locomotor activity after i.c.v. application of NaCl or margatoxin (MgTX) in lean (black) and obese (grey) mice for the 120 min measurement period, n=4. Data are given in counts/min ± SEM (*p<0.05) the inability of insulin to increase locomotor activity in an insulin-resistant state.
To resemble an obese and insulin-resistant phenotype, mice were weaned on a high-fat diet for 8 weeks [21] . Measurements of cortical activity in diet-induced obese mice revealed that insulin injected i.c.v. was not able to increase cortical activity in any of the frequency bands ( Fig. 1 a-h, grey bars) , and this was accompanied by the inability of insulin to increase locomotor activity (Fig. 1j) in obese mice.
Insulin action, cortical activity and locomotion in an animal model of insulin resistance To verify insulin resistance in the brain of mice fed a high-fat diet, western blot analysis and PI3-kinase activity assays were performed. These demonstrated that the activation of the insulin receptor signalling cascade was consistently lower in obese mice because of impaired tyrosine phosphorylation and expression of the insulin receptor and insulin receptor substrate 2 proteins as well as impaired PI3-kinase activity in brain tissues (Fig. 2a) . Measurements of average basal cortical activity revealed a significant reduction in mice fed a high-fat diet compared with lean animals, with the most prominent discrepancy in the slow theta rhythm (Fig. 2b) .
In parallel with the discrepancy in cortical activity, mice displayed significant differences in locomotor activity during the day and night cycle, and mice fed a high-fat diet were less active than lean animals (Fig. 2c, d ). While i.c.v. insulin delivery into lean mice led to a significant increase in locomotor activity compared with saline (Fig. 2e, left panels) , insulin-mediated locomotion was abolished in obese in the 120 min post-injection interval (Fig. 2e, right panels, p>0.05) . Therefore, the metabolic state in diet-induced obese mice is tightly correlated with a . Basal experiments (locomotor activity and ECoG) were jointly performed in C3H/HeJ/TLR2-KO mice and their control group. e Tyrosine phosphorylation of insulin receptor substrate 2 in total brain lysates of mice stimulated with insulin intravenously (Ins). Membranes were reprobed with the respective antibodies to ensure equal protein concentrations. One representative western blot is shown from three independent experiments. β-TUB, β-tubulin. f Locomotor activity of overnight-fasted control (n=4, white bar) and C3H/HeJ/ TLR2-KO mice (n=4, black bar) following i.c.v. application of human insulin (3.75 mU total) for the subsequent 120 min measurement (*p<0.05 compared with control mice). ECoG power increase (% of vehicle) of C3H/HeJ/TLR2-KO mice (n=4) was evaluated in the slow frequency bands, delta (cross-hatched bar) and theta (vertically striped bar), directly after i.c.v. application for the 120 min measurement (*p<0.05 compared with vehicle). Data are given in counts/min ± SEM for locomotor activity and in power increase (% of vehicle) ± SEM for ECoG activity deficit in brain activity in the slow frequency spectrum and physical inactivity that even persists in the face of acutely raising insulin levels in the brain.
Modulation of locomotor activity by a selective inhibitor of the Kv1.3 channel Up to now, the signalling molecules involved in insulin-mediated locomotion have been unknown; however, there is evidence that insulin mediates its function in brain tissues through the phosphorylation of potassium channels and subsequent neurotransmitter expression. In particular, the voltage-dependent Kv1.3 channel is a major candidate as insulin has been shown to inactivate Kv1.3 channels when phosphorylated at multiple sites of the Kv1.3 ion channel protein, and the related pathway involves PI3-kinase [22] . We therefore tested whether Kv1.3 channels are involved in the insulin signalling cascade in brain tissues that potentially induces locomotor activity and used the specific Kv1.3 inhibitor margatoxin to bypass activation of insulin receptors. Application of margatoxin into lean (Fig. 2f , black columns) and obese (Fig. 2f , grey columns) mice profoundly increased locomotor activity, even in obese mice where insulin was unable to promote locomotion. Together, these data suggest that the insulin signalling cascade is disrupted at the levels of the insulin receptor and postreceptor signalling molecules such as IRS2 and PI3-kinase in diet-induced obese mice, while the signalling cascade is intact at the level of Kv1.3 channels.
Cortical activity and locomotion in an animal model of enhanced insulin signalling in the brain To identify potential mediators of insulin resistance in the brain that contribute to impaired activity in frequency bands related to physical activity, a mouse model of deficient Toll-like receptor signalling was screened for cortical activity and locomotion. While Toll-like receptors have been implicated in the pathogenesis of NEFA-induced insulin resistance in the periphery, the role of TLRs with regard to insulin action in the brain is unknown. Consistent with previous results [23] , chow-fed TLR2/4-deficient mice displayed no significant differences in fasting blood glucose levels, glucose tolerance tests (Fig. 3a) or body weight (wild type: 22.9 g± 0.9 g; TLR2/4-deficient: 22.2 g ± 0.6 g). Looking at locomotor activity, mice deficient of TLR2/4 signalling displayed enhanced activity during the day and night cycles ( Fig. 3b and c) , and this was clearly reflected by improved brain activity in the theta frequency band (Fig. 3d) . In parallel, basal as well as insulin-stimulated tyrosine phosphorylation of IRS2 in the brain was significantly enhanced in TLR2/4-deficient mice ( Fig. 3e; p<0.05, n=3) , and was accompanied by significantly increased insulinmediated locomotor activity in TLR2/4-deficient mice (Fig. 3f, left panels) . In keeping with this, insulin modulated cortical activity in the slow frequency bands (Fig. 3f, right panels) to a greater extent in TLR2/4-deficient mice than in controls. Therefore, TLR2/4 signalling seems to be a determinant of impaired brain activity in the slow frequency bands that finally leads to physical inactivity.
Discussion
There is evidence from mouse models that alterations in the insulin signalling pathway in the brain are accompanied by an obese phenotype, and this was recently confirmed also in overweight humans [1, 24] . Here, we show that levels of locomotor activity are dependent on insulin action in the brain as impaired insulin signalling and cortical activity in the slow frequency bands were accompanied by less physical activity. This is supported by a recent study demonstrating that mice with disrupted insulin signalling in the hypothalamus are less active than controls [8] .
While we described a profound correlation of impaired insulin-mediated theta activity in the human brain with obesity [1, 13] , the current data from our mouse models suggest that the decrease in theta activity is accompanied by impaired locomotor activity. This is in accordance with the limited number of studies investigating cortical brain activation during spontaneous locomotion [25] demonstrating that during mental navigation, neocortical and hippocampal theta activity increased [26] , and active exercise resulted in power increases in the theta frequency band [20] . Insulin application into the brain predominantly enhances rhythm in the slow frequency ranges in lean mice, whereas in the presence of a high-fat diet, activity in these frequency bands remained dramatically diminished.
The overall meaning of impaired ECoG power density in obese mice in all of the frequency bands remains unclear from our data. However, former studies suggested that in obese and diabetic individuals, atrophy in the hippocampus occurs and is accompanied by an increased risk for the development of impaired cognitive function [27] [28] [29] [30] [31] . In this regard, functional magnetic resonance imaging studies in combination with cognitive tests in lean and obese individuals are under way to identify the related brain areas.
Although the mechanisms by which obesity causes insulin resistance in the brain are largely unknown, signalling mechanisms through surface receptors such as the TLRs are a proposed link. In particular, TLR2 and TLR4 receptors are expressed in brain tissues and are stimulated by increasing levels of saturated NEFA [32] , and a loss-of-function mutation in TLR4 receptors protects mice from diet-induced obesity and insulin resistance in the periphery [23] ; however, insulin signalling of the brain was not investigated in that experiment. From our study, it now becomes evident that in mice with defective TLR-receptor signalling, insulin action in the brain is enhanced and correlates with improved activity in the slow frequency bands and locomotor activity, suggesting that NEFAs and/ or cytokines from the metabolically active lipid store in the periphery mediate impaired insulin action in the brain that finally leads to physical inactivity in obesity. Compatible with our hypothesis, studies in humans demonstrated that insulin-mediated cortical activity in the theta frequency band is diminished in the presence of elevated levels of saturated NEFAs [33] .
To define the related mechanisms, we demonstrated that insulin promotes locomotor activity by activation of the PI3-kinase pathway and, finally, closure of voltage-gated Kv1.3 potassium channels. Convincing evidence for this mechanism came from pharmacological inhibition of Kv1.3 channels that promoted locomotor activity in lean and even obese mice, and the fact that Kv1.3 knockout mice exhibited significantly increased total activity and lower body weight, while their total energy intake was comparable [34] .
In summary, our data suggest that insulin is a key mediator that couples the metabolic state to electrical activity, and finally locomotion, and therefore closes the gap between insulin-mediated changes in cortical activity and its behavioural consequences. In our understanding, postprandial insulin levels signal the metabolic state to the brain and increase locomotor activity, whereas this circuit is disrupted in the presence of obesity. Thereby, adequate insulin action in the brain is the basis for the maintenance of locomotor activity by activation of brain activity in the slow frequency bands, while in obese mice, this effect is blunted and further aggravates physical inactivity.
